743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.07%
Revenue growth 10-15% – Solid pace. Seth Klarman would see if consistent expansion is reflected in improving net margins.
8.25%
Gross profit growth 5-10% – Moderate. Peter Lynch might look at operating leverage to see if profitability can scale further.
0.50%
EBIT growth 0-5% – Limited. Howard Marks would worry if rising SG&A or R&D is constraining profitability.
0.50%
Operating income growth 0-5% – Barely rising. Howard Marks would be cautious about margin pressure or rising SG&A.
1.78%
Net income growth 0-5% – Barely inching up. Howard Marks would be wary of overhead or macro pressure limiting profitability gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.99%
Share count up to +3% – Slight dilution. Howard Marks would be cautious but might accept it if used for profitable growth investments.
1.11%
Diluted share count up to +3% – Modest dilution. Howard Marks might tolerate it if used for high-ROI projects or strategic acquisitions.
No Data
No Data available this quarter, please select a different quarter.
-6.94%
Negative OCF growth is a critical warning sign. Benjamin Graham would check if receivables are ballooning or if core sales are declining.
-12.16%
Negative FCF growth reveals potential liquidity pressures or large capex overshadowing cash generation. Benjamin Graham would demand deeper scrutiny.
213.43%
10Y revenue/share CAGR above 15% – Exceptional long-term expansion. Warren Buffett would confirm if growth is organic, not purely from acquisitions.
213.43%
5Y CAGR above 15% – Robust mid-term revenue/share growth. Warren Buffett might ensure net margins are rising alongside top-line expansions.
213.43%
3Y CAGR above 15% – Rapid short-term revenue/share growth. Warren Buffett would see if margins are stable, ensuring profitable expansion.
106.20%
10Y OCF/share CAGR above 15% – Outstanding long-term cash-generation growth. Warren Buffett would check if reinvestment needs remain manageable.
106.20%
5Y OCF/share CAGR above 15% – Very robust mid-term cash expansion. Warren Buffett would check if reinvestment fosters sustainable growth.
106.20%
3Y OCF/share CAGR above 15% – Rapid short-term expansion. Warren Buffett would see if this stems from genuine operational improvements vs. working-capital swings.
229.82%
10Y net income/share CAGR above 15% – Exceptional long-term profit growth. Benjamin Graham would confirm if these gains hold through economic cycles.
229.82%
5Y net income/share CAGR above 15% – Strong mid-term profit growth. Benjamin Graham would check if leverage artificially boosts earnings.
229.82%
3Y net income/share CAGR above 15% – Rapid short-term profit growth. Benjamin Graham would verify if it’s driven by core revenue or temporary cost reductions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.54%
Receivables growth 10-15% – Some buildup. Peter Lynch checks if it aligns with similar revenue expansion.
No Data
No Data available this quarter, please select a different quarter.
16.46%
Asset growth 15-20% – Strong. Benjamin Graham verifies whether acquisitions or major capex are sustainable and profitable.
14.63%
Book value/share growth above 12% annually – Strong sign of compounding. Warren Buffett verifies if profits or buybacks mainly drive it.
-14.72%
A negative growth rate in debt means deleveraging, often positive for conservative investors. Benjamin Graham confirms it doesn’t restrict needed investments.
23.58%
R&D growth 20-30% – High. Howard Marks questions ROI unless the pipeline is robust or near commercialization.
14.05%
SG&A growth 10-15% – Potential overhead buildup. Howard Marks questions if margins shrink unless revenue scales accordingly.